Cite
Phosphoproteomics of Primary Cells Reveals Druggable Kinase Signatures in Ovarian Cancer
MLA
Lars Juhl Jensen, et al. “Phosphoproteomics of Primary Cells Reveals Druggable Kinase Signatures in Ovarian Cancer.” Cell Reports, vol. 18, no. 13, Mar. 2017, pp. 3242–56. EBSCOhost, https://doi.org/10.1016/j.celrep.2017.03.015.
APA
Lars Juhl Jensen, Chiara Francavilla, Katarzyna M. Kowalczyk, Rosa Rakownikow Jersie-Christensen, Giovanni Bertalot, Alessandra Villa, Jesper V. Olsen, Ugo Cavallaro, Stefano Confalonieri, Kalliopi Tsafou, Søren Brunak, & Michela Lupia. (2017). Phosphoproteomics of Primary Cells Reveals Druggable Kinase Signatures in Ovarian Cancer. Cell Reports, 18(13), 3242–3256. https://doi.org/10.1016/j.celrep.2017.03.015
Chicago
Lars Juhl Jensen, Chiara Francavilla, Katarzyna M. Kowalczyk, Rosa Rakownikow Jersie-Christensen, Giovanni Bertalot, Alessandra Villa, Jesper V. Olsen, et al. 2017. “Phosphoproteomics of Primary Cells Reveals Druggable Kinase Signatures in Ovarian Cancer.” Cell Reports 18 (13): 3242–56. doi:10.1016/j.celrep.2017.03.015.